It may come as a surprise, but not all weight loss is healthy. And one key question for

Ozempic, Novo Nordisk A/S’s popular diabetes drug that’s also used for weight loss, could be one of the

Sticker shock isn’t slowing Americans’ fervor for weight-loss drugs as a new analysis finds the drugs can cost

Novo Nordisk A/S said the supply of its blockbuster obesity medicine Wegovy will continue to be restricted in

Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the

Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and

Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number

Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question

Obesity shots like Wegovy are already a cultural phenomenon. Now it’s looking like pill forms of the drugs

An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the

Novo Nordisk A/S is spending 15.9 billion Danish kroner ($2.29 billion) to expand production facilities in Denmark as